Cost-Effectiveness of a Home Telemonitoring System for Asian Adults with Type 2 Diabetes Mellitus

被引:1
|
作者
Tan, Sharon Hui Xuan [1 ,2 ]
Ang, Seng Bin [3 ,4 ]
Tan, Ngiap Chuan [5 ,6 ]
Lee, Cia Sin [5 ,6 ]
Koh, Eileen Yi Ling [5 ]
Koh, Gerald Choon Huat [1 ,2 ,3 ]
Wang, Yi [1 ,2 ]
机构
[1] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[2] Natl Univ Hlth Syst, Singapore, Singapore
[3] MOH Off Healthcare Transformat, Future Primary Care, Singapore, Singapore
[4] KK Womens & Childrens Hosp, Singapore, Singapore
[5] SingHlth Polyclin, Res Dept, Singapore, Singapore
[6] SingHlth Duke NUS Family Med Acad Clin Programme, Singapore, Singapore
关键词
telemedicine; primary health care; diabetes mellitus; blood glucose self-monitoring; glycemic control; TELEMEDICINE; EDUCATION;
D O I
10.1089/tmj.2024.0143
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Telemonitoring programs have been found to be effective in improving diabetic control by promoting patients' self-management of diabetes through medication adherence, dietary modifications, and exercise. Nonetheless, few studies have assessed the cost-effectiveness of telemonitoring for the self-management of diabetes based on real-world data.Methods: A randomized controlled trial entitled Optimizing care of Patients via Telehealth In Monitoring and Augmenting their control of Diabetes Mellitus was conducted among adults with Type 2 Diabetes Mellitus in Singapore. Individuals in the intervention group (n = 159) underwent a telemonitoring program comprising of remote patient monitoring, education, individualized health coaching, and teleconsultations, whereas individuals in the control group (n = 160) received regular care. Economic evaluation was conducted from health care system and societal perspectives in 2020 in Singapore dollars, using health outcomes and costs documented at baseline and at 6 month follow-up. One-way sensitivity analyses and bootstrapping to generate scatter plot on cost-effectiveness planes were done.Results: The adjusted reduction in HbA1c scores was greater in the intervention group by -0.41 (95% confidence interval [CI], -0.65 to -0.17), while the change in utility scores was higher in the intervention group by 0.011 (95% CI, -0.016 to 0.0378). From a health care perspective, the incremental cost-effectiveness ratio (ICER) of the telemonitoring program per unit improvement in HbA1c, per additional case of well-controlled diabetes, and per unit improvement in quality adjusted life years was SGD 580.44, SGD 9100.15, and SGD 21,476.36, respectively. From a societal perspective, the ICERs were SGD 817.20, SGD 12,812.02, and SGD 30,236.36, respectively.Conclusions: The Optimizing care of Patients via Telehealth In Monitoring and Augmenting their control of Diabetes Mellitus telemonitoring program was effective and potentially cost-effective for the management and control of diabetes among patients in primary care.
引用
收藏
页码:2353 / 2362
页数:10
相关论文
共 50 条
  • [41] Cost-effectiveness of primary prevention of type 2 diabetes
    Icks, A.
    Chernyak, N.
    Klein, A.
    Brinks, R.
    Genz, J.
    Giani, G.
    DIABETOLOGE, 2011, 7 (02): : 92 - 98
  • [42] COST-EFFECTIVENESS OF EXERCISE PROGRAMS IN TYPE 2 DIABETES
    Coyle, Doug
    Coyle, Kathryn
    Kenny, Glen P.
    Boule, Normand G.
    Wells, George A.
    Fortier, Michelle
    Reid, Robert D.
    Phillips, Penny
    Sigal, Ronald J.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) : 228 - 234
  • [43] Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus
    Lohse, Nicolai
    Marseille, Elliot
    Kahn, James G.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 115 : S20 - S25
  • [44] Pharmacoeconomic Analysis of Sitagliptin/Metformin for the Treatment of Type 2 Diabetes Mellitus: A Cost-Effectiveness Study
    Rojas, Giovanni
    Nunes, Altacilio
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 26 : 33 - 39
  • [45] Cost-Effectiveness Analysis of a Mobile-Based Intervention for Patients with Type 2 Diabetes Mellitus
    Li, Jing
    Sun, Li
    Hou, Yabing
    Chen, Liming
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021
  • [46] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Charalampos Tzanetakos
    Nicholas Tentolouris
    Georgia Kourlaba
    Nikos Maniadakis
    Clinical Drug Investigation, 2016, 36 : 649 - 659
  • [47] Cost-Effectiveness of Bariatric Surgery for Type 2 Diabetes Mellitus A Randomized Controlled Trial in China
    Tang, Qi
    Sun, Zhipeng
    Zhang, Nengwei
    Xu, Guangzhong
    Song, Peipei
    Xu, Lingzhong
    Tang, Wei
    MEDICINE, 2016, 95 (20)
  • [48] A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus
    Chen, THH
    Yen, MF
    Tung, TH
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 54 : S37 - S42
  • [49] Cost-effectiveness analysis of nephroprotection programs for patients with type 2 diabetes mellitus in insurers in Colombia
    Cristian Alejandro González-Rojas
    Sergio Augusto Cáceres-Maldonado
    Luis Alberto Soler-Vanoy
    Lizbeth Alexandra Acuña-Merchán
    Cost Effectiveness and Resource Allocation, 23 (1)
  • [50] Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
    Vega-Hernandez, Gabriela
    Wojcik, Radek
    Schlueter, Max
    DIABETES THERAPY, 2017, 8 (03) : 513 - 530